- Motley Fool•13 hours ago
Carl Icahn has reportedly bought shares in this big-cap biopharma, but Bristol-Myers Squibb might be too big and costly to win an acquirer.
- American City Business Journals•17 hours ago
Harvard Pilgrim Health Care has negotiated new payment contracts with two pharmaceutical companies for expensive drugs, progressing a new kind of payment model that could save millions of dollars down the line. If not, the insurer receives a rebate from the pharmaceutical company, which trickles down into more stable premiums for members. “If you think about it, this is considered groundbreaking but it shouldn’t be,” said Michael Sherman, chief medical officer and senior vice president for health services at Harvard Pilgrim.
- Motley Fool•18 hours ago
In this Valentine's Day edition, Industry Focus explores cholesterol busters, heart surgery, and the latest in anticoagulants.
AMGN : Summary for Amgen Inc. - Yahoo Finance
Amgen Inc. (AMGN)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||172.44 x 200|
|Ask||173.77 x 300|
|Day's Range||171.89 - 174.70|
|52 Week Range||133.64 - 176.85|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||16.86|
|Dividend & Yield||4.60 (2.66%)|
|1y Target Est||N/A|